Treatment of cancer ascites by intraperitoneal administration of a streptococcal preparation OK-432 with fresh human complement—Role of complement-derived chemotactic factor to neutrophils
- 1 January 1986
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 8 (7) , 715-721
- https://doi.org/10.1016/0192-0561(86)90007-x
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Polymorphonuclear Leukocyte-Mediated, Antibody-Dependent, Cellular Cytotoxicity against Tumor Cells: Dependence on Oxygen and the Respiratory BurstThe Journal of Immunology, 1979
- ANTIBODY AND COMPLEMENT-MEDIATED CYTOTOXICITY OF NUCLEATED CELLS INHIBITION BY THE SERA OF PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIATransplantation, 1978
- The heterocytotoxicity of human serumCellular Immunology, 1977
- The heterocytotoxicity of human serumCellular Immunology, 1977
- Activation of the alternative complement pathway by lymphoblastoid cell lines derived from patients with Burkitt's lymphoma and infectious mononucleosisCellular Immunology, 1976
- C1-ESTERASE INACTIVATORS AND C4 IN MALIGNANT DISEASESThe Lancet, 1975
- Defective Regulation of Inflammatory Mediators in Hodgkin's DiseaseNew England Journal of Medicine, 1974
- INTERACTIONS OF THE COMPLEMENT SYSTEM WITH ENDOTOXIC LIPOPOLYSACCHARIDEThe Journal of Experimental Medicine, 1968
- Studies on the Anticancer and Streptolysin S‐Forming Abilities of Hemolytic StreptococciJapanese Journal of Microbiology, 1967
- THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITROThe Journal of Experimental Medicine, 1965